- ByInvesting.com
- •
Pharmally International Holding Company Limited develops, produces, and sells large volume parental (LVP) and active pharmaceutical ingredient (API) products in Taiwan and internationally. The company offers basic LVP products, including 5% and 10% glucose, sodium chloride, and glucose sodium chloride injections; and therapeutic LVP products, such as flerofloxacin and glucose, compound mannitol, compound sodium chloride, mannitol, glycerol fructose and sodium chloride, metronidazole and sodium chloride, levofloxacin and glucose, tinidazole and sodium chloride, ambroxol hydrochloride and glucose, betahistine hydrochloride and sodium chloride, ofloxacin and sodium chloride, dextran 20 glucose, dextran 40 sodium chloride, and dextran 40 glucose injections. It also provides API products comprising nikethamide, levofloxacin lactate, and dextran. In addition, the company produces animal vaccines. Pharmally International Holding Company Limited was founded in 2013 and is based in Taipei City, Taiwan.